Christoph Hoeller

10PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Feb 23, 2025
Rare Lacrimal Gland Melanoma: A Case Report and Treatment Insights.

Reinhard Told, Ana-Iris Schiefer, Christoph Hoeller

|Jan 17, 2025
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).

Julia Maria Ressler, Maud Plaschka, Rita Silmbrod

|Sep 28, 2024
BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis.

Sonja Dorfer, Julia Maria Ressler, Katharina Riebenbauer

|Jan 04, 2024
Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.

John M Kirkwood, Michele Del Vecchio, Jeffrey Weber

|Nov 04, 2023
Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.

John M Kirkwood, Michele Del Vecchio, Jeffrey Weber

Pageof 2

Frequent Collaborators

5 joint publications

Paolo A Ascierto

5 joint publications

Georgina V Long

4 joint publications

John M Kirkwood

3 joint publications

Julia Maria Ressler